Home > Boards > US Listed > Biotechs > BG Medicine, Inc. (BGMD)

It is interesting: DEF-14A 06/23/2016… Board of Directors

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
max0001 Member Profile
 
Followed By 0
Posts 24
Boards Moderated 0
Alias Born 12/07/17
160x600 placeholder
max0001   Tuesday, 07/17/18 10:56:58 AM
Re: None
Post # of 1948 
It is interesting: DEF-14A 06/23/2016… Board of Directors currently consists of five members, classified into three classes as follows: Jeffrey R. Luber and Stelios Papadopoulos, Ph.D. constitute a class I with a term ending at our annual meeting of stockholders to be held in 2018; James F. O’Connor constitutes a class II with a term ending at our 2016 annual meeting of stockholders; and Harry W. Wilcox and Paul R. Sohmer, M.D. constitute a class III with a term ending at our annual meeting of stockholders to be held in 2017. On March 25, 2016, our Board of Directors accepted the recommendation of the Nominating and Governance Committee and voted to nominate James F. O’Connor for election at the annual meeting for a term of three years to serve until the 2019 annual meeting of stockholders…Manipulation: 200 sell (-42%) ?2018 annual meeting of stockholders...?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist